Arsphenamine

WikiDoc Resources for Arsphenamine
Articles
Most recent articles on Arsphenamine Most cited articles on Arsphenamine Review articles on Arsphenamine Articles on Arsphenamine in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Arsphenamine Images of Arsphenamine Photos of Arsphenamine Podcasts & MP3s on Arsphenamine Videos on Arsphenamine
Evidence Based Medicine
Cochrane Collaboration on Arsphenamine Bandolier on Arsphenamine TRIP on Arsphenamine
Clinical Trials
Ongoing Trials on Arsphenamine at Clinical Trials.gov Trial results on Arsphenamine Clinical Trials on Arsphenamine at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Arsphenamine NICE Guidance on Arsphenamine NHS PRODIGY Guidance FDA on Arsphenamine CDC on Arsphenamine
Books
Books on Arsphenamine
News
Arsphenamine in the news Be alerted to news on Arsphenamine News trends on Arsphenamine
Commentary
Blogs on Arsphenamine
Definitions
Definitions of Arsphenamine
Patient Resources / Community
Patient resources on Arsphenamine Discussion groups on Arsphenamine Patient Handouts on Arsphenamine Directions to Hospitals Treating Arsphenamine Risk calculators and risk factors for Arsphenamine
Healthcare Provider Resources
Symptoms of Arsphenamine Causes & Risk Factors for Arsphenamine Diagnostic studies for Arsphenamine Treatment of Arsphenamine
Continuing Medical Education (CME)
CME Programs on Arsphenamine
International
Arsphenamine en Espanol Arsphenamine en Francais
Business
Arsphenamine in the Marketplace Patents on Arsphenamine
Experimental / Informatics
List of terms related to Arsphenamine

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

The structure of arsphenamine has been proposed to be akin to the azobenzene (A), but crystallographic studies published in 2005 indicate that it is a mixture of the trimer B and the pentamer C

Arsphenamine is a drug that was used to treat syphilis and trypanosomiasis. It was the first modern chemotherapeutic agent.

History

Sahachiro Hata discovered the anti-syphilitic activity of this compound in 1908 in the laboratory of Paul Ehrlich, during a survey of hundreds of newly-synthesized organic arsenical compounds. Ehrlich had theorized that by screening many compounds a drug could be discovered with anti-microbial activity. Ehrlich's team began their search for such a "magic bullet" among chemical derivatives of the dangerously-toxic drug atoxyl. This was the first organized team effort to optimize the biological activity of a lead compound through systematic chemical modifications, the basis for nearly all modern pharmaceutical research.

Arsphenamine was marketed under the trade name Salvarsan in 1910. It was also called 606, because it was the 606th compound synthesized for testing. Salvarsan was the first organic anti-syphillitic, and a great improvement over the inorganic mercury compounds that had been used previously. A more soluble (but slightly less effective) arsenical compound, Neosalvarsan, (neoarsphenamine), became available in 1912. These arsenical compounds came with considerable risk of side effects, and they were supplanted as treatments for syphilis in the 1940s by penicillin.

The bacterium that causes syphilis is a spirochete, Treponema pallidum. Arsphenamine is not toxic to spirochetes until it has been converted to an active form by the body, so the discovery of this drug could not have been made without Hata's animal testing.

After leaving Erlich's laboratory, Hata continued parallel investigation of the new medicine in Japan.

Structure

The structure was believed to feature an As=As bond, however, in 2005, it was shown to be a mixture of the cyclic trimer and a pentamer. The revised structure features As-As single bonds, not double bonds.

References

Cost Effectiveness of Arsphenamine

| group5 = Clinical Trials Involving Arsphenamine | list5 = Ongoing Trials on Arsphenamine at Clinical Trials.gov • Trial results on Arsphenamine • Clinical Trials on Arsphenamine at Google

| group6 = Guidelines / Policies / Government Resources (FDA/CDC) Regarding Arsphenamine | list6 = US National Guidelines Clearinghouse on Arsphenamine • NICE Guidance on Arsphenamine • NHS PRODIGY Guidance • FDA on Arsphenamine • CDC on Arsphenamine

| group7 = Textbook Information on Arsphenamine | list7 = Books and Textbook Information on Arsphenamine

| group8 = Pharmacology Resources on Arsphenamine | list8 = AND (Dose)}} Dosing of Arsphenamine • AND (drug interactions)}} Drug interactions with Arsphenamine • AND (side effects)}} Side effects of Arsphenamine • AND (Allergy)}} Allergic reactions to Arsphenamine • AND (overdose)}} Overdose information on Arsphenamine • AND (carcinogenicity)}} Carcinogenicity information on Arsphenamine • AND (pregnancy)}} Arsphenamine in pregnancy • AND (pharmacokinetics)}} Pharmacokinetics of Arsphenamine •

| group9 = Genetics, Pharmacogenomics, and Proteinomics of Arsphenamine | list9 = AND (pharmacogenomics)}} Genetics of Arsphenamine • AND (pharmacogenomics)}} Pharmacogenomics of Arsphenamine • AND (proteomics)}} Proteomics of Arsphenamine

| group10 = Newstories on Arsphenamine | list10 = Arsphenamine in the news • Be alerted to news on Arsphenamine • News trends on Arsphenamine</small>

| group11 = Commentary on Arsphenamine | list11 = Blogs on Arsphenamine

| group12 = Patient Resources on Arsphenamine | list12 = Patient resources on Arsphenamine • Discussion groups on Arsphenamine • Patient Handouts on Arsphenamine • Directions to Hospitals Treating Arsphenamine • Risk calculators and risk factors for Arsphenamine

| group13 = Healthcare Provider Resources on Arsphenamine | list13 = Symptoms of Arsphenamine • Causes & Risk Factors for Arsphenamine • Diagnostic studies for Arsphenamine • Treatment of Arsphenamine

| group14 = Continuing Medical Education (CME) Programs on Arsphenamine | list14 = CME Programs on Arsphenamine

| group15 = International Resources on Arsphenamine | list15 = Arsphenamine en Espanol • Arsphenamine en Francais

| group16 = Business Resources on Arsphenamine | list16 = Arsphenamine in the Marketplace • Patents on Arsphenamine

| group17 = Informatics Resources on Arsphenamine | list17 = List of terms related to Arsphenamine

}}